Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.eRT.com) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development.
Statements included in this release may constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform
Act of 1995. Such statements, including, but not limited to, 2007 financial
guidance, involve a number of risks and uncertainties such as the company's
ability to obtain new contracts and accurately estimate net revenues due to
uncertain regulatory guidance, variability in size, scope and duration of
projects, and internal issues at the sponsoring client, competitive
factors, technological development, and market demand. As a result, actual
results may differ materially from any financial outlooks stated herein.
Further information on potential factors that could affect the company's
financial results can be found in the company's Report on Form 10-K and 10Q
filed with the Securities and Exchange Commission. The company undertakes
no obligation to publicly update any forward-looking statement,
|SOURCE eResearchTechnology, Inc.|
Copyright©2007 PR Newswire.
All rights reserved